Erin Wright
Stock Analyst at Morgan Stanley
(1.51)
# 3,168
Out of 4,829 analysts
217
Total ratings
100%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Overweight | $20 → $25 | $22.35 | +11.86% | 3 | May 9, 2025 | |
| PAHC Phibro Animal Health | Maintains: Equal-Weight | $20 → $21 | $24.50 | -14.29% | 22 | May 8, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $548 → $558 | $509.53 | +9.51% | 13 | May 5, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $379 → $390 | $315.74 | +23.52% | 5 | May 5, 2025 | |
| CAH Cardinal Health | Maintains: Overweight | $142 → $166 | $148.62 | +11.69% | 10 | May 5, 2025 | |
| PETS PetMed Express | Maintains: Underweight | $3.5 → $3.2 | $3.72 | -13.98% | 12 | Apr 17, 2025 | |
| MCK McKesson | Maintains: Overweight | $642 → $745 | $687.52 | +8.36% | 6 | Apr 2, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $19 | $18.55 | +2.43% | 8 | Mar 6, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $14 → $13 | $12.82 | +1.40% | 11 | Feb 26, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $243 → $238 | $161.92 | +46.99% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $301 → $285 | $252.86 | +12.71% | 3 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $272 | $189.00 | +43.92% | 21 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $16.75 | +37.31% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $175.90 | -2.22% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $643 → $551 | $416.69 | +32.23% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $9 → $7 | $11.40 | -38.60% | 7 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $69 → $65 | $70.47 | -7.76% | 4 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $64.81 | +54.30% | 4 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $378.75 | +54.98% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $250.94 | +19.55% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $13.00 | +223.08% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $200.83 | +43.40% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $143.08 | +146.02% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $2.12 | +1,975.47% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $313.74 | -42.31% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $79.52 | -78.62% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $39.48 | +206.48% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $432.59 | +34.08% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $12.13 | +188.54% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $140.22 | +46.20% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $20.12 | -45.33% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $156.13 | +0.56% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $23.01 | +65.15% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $7.15 | +137.76% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $473.16 | -34.91% | 1 | Oct 25, 2017 |
BrightSpring Health Services
May 9, 2025
Maintains: Overweight
Price Target: $20 → $25
Current: $22.35
Upside: +11.86%
Phibro Animal Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $24.50
Upside: -14.29%
IDEXX Laboratories
May 5, 2025
Maintains: Overweight
Price Target: $548 → $558
Current: $509.53
Upside: +9.51%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $315.74
Upside: +23.52%
Cardinal Health
May 5, 2025
Maintains: Overweight
Price Target: $142 → $166
Current: $148.62
Upside: +11.69%
PetMed Express
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.72
Upside: -13.98%
McKesson
Apr 2, 2025
Maintains: Overweight
Price Target: $642 → $745
Current: $687.52
Upside: +8.36%
Envista Holdings
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $18.55
Upside: +2.43%
Elanco Animal Health
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $12.82
Upside: +1.40%
Zoetis
Feb 14, 2025
Maintains: Overweight
Price Target: $243 → $238
Current: $161.92
Upside: +46.99%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $301 → $285
Current: $252.86
Upside: +12.71%
Feb 6, 2025
Maintains: Overweight
Price Target: $280 → $272
Current: $189.00
Upside: +43.92%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $16.75
Upside: +37.31%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $175.90
Upside: -2.22%
Oct 23, 2024
Maintains: Overweight
Price Target: $643 → $551
Current: $416.69
Upside: +32.23%
Oct 11, 2024
Maintains: Underweight
Price Target: $9 → $7
Current: $11.40
Upside: -38.60%
Nov 14, 2023
Maintains: Underweight
Price Target: $69 → $65
Current: $70.47
Upside: -7.76%
Nov 2, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $64.81
Upside: +54.30%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $378.75
Upside: +54.98%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $250.94
Upside: +19.55%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $13.00
Upside: +223.08%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $200.83
Upside: +43.40%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $143.08
Upside: +146.02%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $2.12
Upside: +1,975.47%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $313.74
Upside: -42.31%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $79.52
Upside: -78.62%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $39.48
Upside: +206.48%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $432.59
Upside: +34.08%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $12.13
Upside: +188.54%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $140.22
Upside: +46.20%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $20.12
Upside: -45.33%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $156.13
Upside: +0.56%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $23.01
Upside: +65.15%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $7.15
Upside: +137.76%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $473.16
Upside: -34.91%